APP and Alzheimer disease: Particularly, phosphorylation of APP at T668 (APP695 isoform numbering) increases the beta product levels by facilitating exposure to and cleavage by BACE in human patients with AD and transgenic models (Lee et al., 2003; Shin et al., 2007).